Mast cell activation in arthritis: Detection of α- and β-tryptase, histamine and eosinophil cationic protein in synovial fluid

Clinical Science

Volumn 93, Issue 4, 1997, Pages 363-370

  Buckley, M G ^a   Walters, C ^a   Wong, W M ^a   Cawley, M I D ^a   Ren, S ^b   Schwartz, L B ^b   Walls, A F ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arthritis; Eosinophil cation protein; Histamine; Mast cell; Synovial fluid; Tryptase

Indexed keywords

ALPHA TRYPTASE; BETA TRYPTASE; CELL ENZYME; EOSINOPHIL CATIONIC PROTEIN; HISTAMINE; MONOCLONAL ANTIBODY; RECOMBINANT ENZYME; TRYPTASE; UNCLASSIFIED DRUG;

ADULT; AGED; ANAPHYLAXIS; ARTHRITIS; ARTHROPATHY; ARTICLE; CELL COUNT; CONTROLLED STUDY; ENZYME RELEASE; ENZYME SUBUNIT; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; MAST CELL; MAST CELL DEGRANULATION; OSTEOARTHRITIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RHEUMATOID ARTHRITIS; SPONDYLOSIS; SYNOVIAL FLUID; SYNOVITIS;

EID: 0030694130     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0930363     Document Type: Article

References (37)

1. Malone DG, Wilder RL, Saavedra-Delgado AM, Metcalfe DD. Mast cell numbers in rheumatoid synovial tissues. Correlations with quantitative measures of lymphocytic infiltration and modulation by antiinflammatory therapy. Arthritis Rheum 1987; 30: 130-7.
2. Tetlow LC, Woolley DE. Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion. Ann Rheum Dis 1995; 54: 549-55.
3. Dean G, Hoyland JA, Denton J, Donn RP, Freemont AJ. Mast cells in the synovium and synovial fluid in osteoarthritis. Br J Rheumatol 1993; 32: 671-5.
4. Malone DG, Irani A-M, Schwanz LB, Barrett KE, Metcalfe DD. Mast cell numbers and histamine levels in synovial fluids from patients with diverse arthritides. Arthritis Rheum 1986; 29: 956-63.
5. Tetlow LC, Woolley DE. Mast cells, cytokines and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies. Ann Rheum Dis 1995; 54: 896-903.
6. Crisp AJ, Chapman CM, Kirkham SE, Schiller AL, Krane SM. Articular mastocytosis in rheumatoid arthritis. Arthritis Rheum 1984; 27: 845-51.
7. Walls AF. The roles of neutral proteases in asthma and rhinitis. In Busse WW, Holgate ST, eds. Asthma and rhinitis. Boston: Blackwell Scientific, 1995: 801-24.
8. Miller JS, Moxley G, Schwanz LB. Cloning and characterization of a second complementary DNA for human tryptase. J din Invest 1990; 86: 864-70.
9. Sakai K, Ren S, Schwartz LB. A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I. J Clin Invest 1996; 97: 988-95.
10. Tarn EK, Caughey GH. Degradation of airway neuropeptides by human lung tryptase. Am J Respir Cell Mol Biol 1990; 3: 27-32.
11. Walls AF, Brain SD, Desai A, et al. Human mast cell tryptase attenuates the vasodilator activity of calcitonin gene-related peptide. Biochem Pharmacol 1992; 43: 1243-8.
12. Gruber BL, Schwartz LB, Ramamurthy NS, Irani A-M, Marchese MJ. Activation of latent rheumatoid synovial collagenase by human mast cell tryptase. J Immunol 1988; 140: 3936-42.
13. Ruoss SJ, Hartmann T, Caughey GH. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 1991; 88: 493-9.
14. Cairns JA, Walls AF. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest 1997; 99: 1313-21.
15. Buckley MG, Gallagher PJ, Walls AF. Altered protease content in the mast cells of patients with osteoarthritis. Immunology 1995; 86 (Suppl. 1): 75.
16. Saarinen J, Kalkkinen N, Welgus HG, Kovanen PT. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. J Biol Chem 1994; 269: 18134-40.
17. Mizutani H, Schlechter N, Lazarus G, Black RA, Kupper TS. Rapid and specific conversion of precursor interleukin 1 βf (IL-1 β) to an active IL-1 species by human mast cell chymase. J Exp Med 1991; 174: 821-5.
18. Tunon de Lara JM, Okayama Y, McEuen AR, Heusser CH, Church MK, Walls AF. Release and inactivation of interleukin-4 by mast cells. Ann NY Acad Sci 1994; 725: 50-8.
19. Árnason JA, Malone DG. Role of mast cells in arthritis. Chem Immunol. 1995; 62: 204-38.
20. Qu Z, Huang X-N, Ahmad P, et al. Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease. Lab Invest 1995; 73: 339-46.
21. Walls AF, Jones DB, Williams JH, Church MK, Holgate ST. Immunohistochemical identification of mast cells in formaldehyde-fixed tissue using monoclonal antibodies specific for tryptase. J Pathol 1990; 162: 119-26.
22. Castells MC, Irani AM, Schwartz LB. Evaluation of human peripheral blood leukocytes for mast cell tryptase. J Immunol 1987; 138: 2184-9.
23. Schwartz LB. Laboratory assessment of immediate hypersensitivity and anaphylaxis. Use of tryptase as a marker of mast cell-dependent events. Immunol Allergy Clin N Am 1994; 14: 339-49.
24. Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T. Tryptase levels as an indicator of mast cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987; 316: 1622-6.
25. Lavery JP, Lisse JR. Preliminary study of the tryptase levels in the synovial fluid of patients with inflammatory arthritis. Ann Allergy 1994; 72: 425-7.
26. Brodeur JP, Ruddy S, Schwanz LB, Moxley G. Synovial fluid levels of complement SCSb-9 and fragment Bb are elevated in patients with rheumatoid arthritis. Arthritis Rheum 1991; 34: 1531-7.
27. Schwanz LB, Sakai K, Bradford TR, et al. The α form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 1995; 96: 2702-10.
28. Walls AF, Bennett AR, McBride HM, Glennie MJ, Holgate ST, Church MK. Production and characterisation of monoclonal antibodies specific for human mast cell tryptase. Clin Exp Allergy 1990; 20: 581-9.
29. Sakai K, Long SD, Pettit DAD, Cabrai GA, Schwanz LB. Expression and purification of recombinant human tryptase in a baculovirus system. Protein Expr Purif 1996; 7: 67-73.
30. Gruber B. Activation of rheumatoid synovial mast cells. Role of IgE-associated antiglobulins. Monogr Allergy 1989; 26: 120-34.
31. Cooper AL, Snowden N, Woolley DE. IgE antibodies specific for cartilage collagens type II, IX and XI in rheumatic diseases. Scand J Rheumatol 1993; 22: 207-14.
32. Church MK, El-Lati S, Caulfield JP. Neuropeptide-induced secretion from human skin mast cells. Int Arch Allergy Appl Immunol 1991; 94: 310-18.
33. Gruber B, Poznansky M, Boss E, Partin J, Gorevic P, Kaplan AP. Characterization and functional studies of rheumatoid synovial mast cells. Arthritis Rheum 1986; 29: 944-55.
34. Van Overveld FJ, Jorens PG, Rampart M, de Backer W, Vermeire L. Tumour necrosis factor stimulates human skin mast cells to release histamine and tryptase. Clin Exp Allergy 1991; 21: 711-14.
35. Columbo M, Horowitz AM, Botana LM, et al. The human recombinant c-kit ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 1991; 149: 599-608.
36. Hällgren R, Feltelius N, Svenson K, Venge P. Eosinophil involvement in rheumatoid arthritis as reflected by elevated serum levels of eosinophil cationic protein. Clin Exp Immunol 1985; 59: 539-46.
37. Abu-Ghazaleh RI, Dunnette SL, Loegering DA, et al. Eosinophil granule proteins in peripheral blood granulocytes. J Leukocyte Biol 1992; 52: 611-18.